[HTML][HTML] Factors predicting malignancy in patients with polymyositis and dermatomyostis: a systematic review and meta-analysis

…, H Yang, X Shu, F Chen, Y Zhang, S Zhang, Q Peng… - PLoS …, 2014 - journals.plos.org
Objective To define potential factors that could predict concomitant neoplastic diseases in
patients diagnosed with PM/DM, which could inform screening decisions. Methods Two …

[HTML][HTML] Identification of multiple cancer-associated myositis-specific autoantibodies in idiopathic inflammatory myopathies: a large longitudinal cohort study

H Yang, Q Peng, L Yin, S Li, J Shi, Y Zhang… - Arthritis research & …, 2017 - Springer
Background Cancer is a significant complication contributing to increased mortality in idiopathic
inflammatory myopathies (IIMs), and the association between IIMs and cancer has been …

Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study

…, N Bizzaro, M Infantino, T Imbastaro, Q Peng… - Autoimmunity …, 2016 - Elsevier
In an effort to find naturally occurring substances that reduce cholesterol by inhibiting 3-hydroxy-3-methylglutaryl-coenzyme
A reductase (HMGCR), statins were first discovered by Endo …

Clinical profiles and prognosis of patients with distinct antisynthetase autoantibodies

J Shi, S Li, H Yang, Y Zhang, Q Peng, X Lu… - The Journal of …, 2017 - jrheum.org
Objective. To compare the clinical characteristics and identify the longterm outcomes of
Chinese patients with different antisynthetase antibodies. Methods. We investigated …

[HTML][HTML] Clinical characteristics of anti-3-hydroxy-3-methylglutaryl coenzyme A reductase antibodies in Chinese patients with idiopathic inflammatory myopathies

Y Ge, X Lu, Q Peng, X Shu, G Wang - PLoS One, 2015 - journals.plos.org
Objective The objective of this study was to detect the prevalence of anti-3-hydroxyl-3-
methylglutaryl coenzyme A reductase (anti-HMGCR) antibodies in Chinese patients with …

[HTML][HTML] Clinical characteristics of anti-SAE antibodies in Chinese patients with dermatomyositis in comparison with different patient cohorts

Y Ge, X Lu, X Shu, Q Peng, G Wang - Scientific Reports, 2017 - nature.com
This study aimed to analyze the clinical features of anti-SAE antibodies in Chinese myositis
patients in comparison with different cohorts. The anti-SAE antibodies were tested in myositis …

Cyclophosphamide treatment for idiopathic inflammatory myopathies and related interstitial lung disease: a systematic review

Y Ge, Q Peng, S Zhang, H Zhou, X Lu, G Wang - Clinical rheumatology, 2015 - Springer
The purpose of this study is to review and summarize published information on the use,
effectiveness, and adverse effects of cyclophosphamide (CYC) in the management of idiopathic …

The spectrum and clinical significance of myositis-specific autoantibodies in Chinese patients with idiopathic inflammatory myopathies

S Li, Y Ge, H Yang, T Wang, X Zheng, Q Peng… - Clinical …, 2019 - Springer
Objectives The aim of this study is to analyze the prevalence of myositis-specific autoantibodies
(MSAs) and to elucidate their associations with clinical features in Chinese patients with …

Peripheral lymphocyte count defines the clinical phenotypes and prognosis in patients with anti‐MDA5‐positive dermatomyositis

…, W Jiang, X Shu, X Lu, G Wang, Q Peng - Journal of Internal …, 2023 - Wiley Online Library
Peripheral lymphocyte count defines the clinical phenotypes and prognosis in patients with
antiâ•’MDA5â•’positive derm Page 1 This article has been accepted for publication and …

The efficacy of tacrolimus in patients with refractory dermatomyositis/polymyositis: a systematic review

Y Ge, H Zhou, J Shi, B Ye, Q Peng, X Lu, G Wang - Clinical rheumatology, 2015 - Springer
The purpose of this study is to examine the efficacy and safety of tacrolimus (FK506) in the
management of polymyositis (PM)/dermatomyositis (DM). The Cochrane Central Register of …